A preliminary analysis of microRNA as potential clinical biomarker for schizophrenia

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 168, Issue 3, 2015, Pages 170-178

  Sun, Xin Yang ^a,d   Zhang, Jin ^b   Niu, Wei ^a   Guo, Wei ^a   Song, Hong Tao ^c   Li, Heng Yu ^d   Fan, Hui Min ^d   Zhao, Lin ^e   Zhong, Ai Fang ^a   Dai, Yun Hua ^g   Guo, Zhong Min ^h   Zhang, Li Yi ^a   Lu, Jim ^g,h   Zhang, Qiao Li ^f  

^a Hospital of Chinese People's Liberation Army   (China)

^b JIANGSU UNIVERSITY   (China)

^c BENGBU MEDICAL COLLEGE   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e Suzhou City Hospital   (China)

^f XUZHOU MEDICAL UNIVERSITY   (China)

^g GoPath Diagnostic Laboratories   (China)

^h GoPath Laboratory LLC   (United States)

Author keywords

Antipsychotics; Biomarker; CGI; GAS; MicroRNA; PANSS; QPCR; Schizophrenia

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 132; MICRORNA 137; MICRORNA 181B; MICRORNA 195; MICRORNA 212; MICRORNA 30E; MICRORNA 346; MICRORNA 34A; MICRORNA 432; MICRORNA 7; OLANZAPINE; QUETIAPINE; RISPERIDONE; UNCLASSIFIED DRUG; ZIPRASIDONE; NEUROLEPTIC AGENT; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; ASSESSMENT OF HUMANS; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE EXPRESSION; GLOBAL ASSESSMENT SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROGNOSIS; RNA ANALYSIS; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT RESPONSE; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DRUG EFFECTS; FOLLOW UP; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84925637275     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32292     Document Type: Article

References (37)

1. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rašin M-R, Gunel M. 2005. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310(5746):317-320.
2. Bajestan SN, Sabouri AH, Nakamura M, Takashima H, Keikhaee MR, Behdani F, Fayyazi MR, Sargolzaee MR, Bajestan MN, Sabouri Z. 2006. Association of AKT1 haplotype with the risk of schizophrenia in Iranian population. Am J Med Genet Part B Neuropsychiatr Genet 141(4):383-386.
3. Beveridge N, Gardiner E, Carroll A, Tooney P, Cairns M. 2009. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatr 15(12):1176-1189.
4. Beveridge NJ, Tooney PA, Carroll AP, Gardiner E, Bowden N, Scott RJ, Tran N, Dedova I, Cairns MJ. 2008. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet 17(8):1156-1168.
5. Chang TC, Wentzel Ea Fau - Kent OA, Kent Oa Fau - Ramachandran K, Ramachandran K Fau - Mullendore M, Mullendore M Fau - Lee KH, Lee Kh Fau - Feldmann G, Feldmann G Fau - Yamakuchi M, Yamakuchi M Fau - Ferlito M, Ferlito M Fau - Lowenstein CJ, Lowenstein Cj Fau - Arking DE, Arking De Fau - Beer MA, Beer Ma Fau - Maitra A, Maitra A Fau - Mendell JT, Mendell JT. 2007. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis 26(5):745-752.
6. Consortium SPG-WAS. 2011. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43(10):969-976.
7. Cox MB, Cairns MJ, Gandhi KS, Carroll AP, Moscovis S, Stewart GJ, Broadley S, Scott RJ, Booth DR, Lechner-Scott J. 2010. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One 5(8):e12132.
8. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. 2004. Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia. Nat Genet 36(2):131-137.
9. Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang K-Y, Huganir RL. 2005. Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 77(6):918-936.
10. Feng J, Sun G, Yan J, Noltner K, Li W, Buzin CH, Longmate J, Heston LL, Rossi J, Sommer SS. 2009. Evidence for X-chromosomal schizophrenia associated with microRNA alterations. PLoS One 4(7):e6121.
11. Gardiner E, Beveridge N, Wu J, Carr V, Scott R, Tooney P, Cairns M. 2011. Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells. Mol Psychiatry 17(8):827-840.
12. Guo S-Z, Huang K, Shi Y-Y, Tang W, Zhou J, Feng G-Y, Zhu S-M, Liu H-J, Chen Y, Sun X-D. 2007. A Case-control association study between the GRID1 gene and schizophrenia in the Chinese Northern Han population. Schizophr Res 93(1):385-390.
13. Hansen T, Olsen L, Lindow M, Jakobsen KD, Ullum H, Jonsson E, Andreassen OA, Djurovic S, Melle I, Agartz I. 2007. Brain expressed microRNAs implicated in schizophrenia etiology. PloS one 2(9):e873.
14. Hunsberger JG, Austin DR, Chen G, Manji HK. 2009. MicroRNAs in mental health: from biological underpinnings to potential therapies. Neuromolecular Med 11(3):173-182.
15. Kawanishi Y, Tachikawa H, Suzuki T. 2000. Pharmacogenomics and schizophrenia. Eur J Pharmacol 410(2):227-241.
16. Killackey E, Yung AR. 2007. Effectiveness of early intervention in psychosis. Curr Opin Psychiatry 20(2):121-125.
17. Kim AH, Reimers M, Maher B, Williamson V, McMichael O, McClay JL, van den Oord EJ, Riley BP, Kendler KS, Vladimirov VI. 2010. MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr Res 124(1):183-191.
18. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A. 2007. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317(5842):1220-1224.
19. Kroh EM, Parkin RK, Mitchell PS, Tewari M. 2010. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50(4):298-301.
20. Lai C-Y, Yu S-L, Hsieh MH, Chen C-H, Chen H-Y, Wen C-C, Huang Y-H, Hsiao P-C, Hsiao CK, Liu C-M. 2011. MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PloS one 6(6):e21635.
21. Lakhan SE, Kramer A. 2009. Schizophrenia genomics and proteomics: are we any closer to biomarker discovery. Behav Brain Funct 5(2):1-9.
22. Marazziti D, Catena Dell'Osso, Baroni M, Masala S, Dell'Osso I, Consoli B, Giannaccini G, Betti G, Lucacchini L. 2010. Alterations of the dopamine transporter in resting lymphocytes of patients with different psychotic disorders. Psychiatr Res 175(1):54-57.
23. Mellios N, Huang H-S, Baker SP, Galdzicka M, Ginns E, Akbarian S. 2009. Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry 65(12):1006-1014.
24. Miller BH, Zeier Z Fau - Xi L, Xi L Fau - Lanz TA, Lanz Ta Fau - Deng S, Deng S Fau - Strathmann J, Strathmann J Fau - Willoughby D, Willoughby D Fau - Kenny PJ, Kenny Pj Fau - Elsworth JD, Elsworth Jd Fau - Lawrence MS, Lawrence Ms Fau - Roth RH, Roth Rh Fau - Edbauer D, Edbauer D Fau - Kleiman RJ, Kleiman Rj Fau - Wahlestedt C, Wahlestedt C. 2012. MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. (1091 -6490 (Electronic)) 109(8):3125-3130.
25. Pepe MS, Cai T, Longton G. 2006. Combining predictors for classification using the area under the receiver operating characteristic curve. Biometrics 62(1):221-229.
26. Pepe MS, Thompson ML. 2000. Combining diagnostic test results to increase accuracy. Biostatistics 1(2):123-140.
27. Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA, Parker JS, Jin J, Hammond SM. 2007. MicroRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 8(2):R27.
28. Schipper HM, Maes OC, Chertkow HM, Wang E. 2007. MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul Sys Biol 1:263.
29. Schwarz E, Bahn S. 2008a. Biomarker discovery in psychiatric disorders. Electrophoresis 29(13):2884-2890.
30. Schwarz E, Bahn S. 2008b. The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders. Br J Pharmacol 153(S1) S133-S136.
31. Shi W, Du J, Qi Y, Liang G, Wang T, Li S, Xie S, Zeshan B, Xiao Z. 2012. Aberrant expression of serum miRNAs in schizophrenia. J Psychiatr Res 46(2):198-204.
32. Song H-t, Sun X-y, Zhang L, Zhao L, Guo Z-m, Fan H-m, Zhong A-f, Niu W. 2014. A preliminary analysis of association between the down-regulation of microRNA-181b expression and symptomatology improvement in schizophrenia patients before and after antipsychotic treatment. J Psychiatr Res 54:134-140.
33. Thomson JM, Parker J, Perou CM, Hammond SM. 2004. A custom microarray platform for analysis of microRNA gene expression. Nat Methods 1(1):47-53.
34. Vawter MP, Barrett T, Cheadle C, Sokolov BP, Wood III, Donovan WH, Webster DM, Freed M, Becker WJ. 2001. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 55(5):641-650.
35. Wang Y, Zheng D, Tan Q, Wang MX, Gu L-Q. 2011. Nanopore-based detection of circulating microRNAs in lung cancer patients. Nature Nanotechnol 6(10):668-674.
36. Xu Y, Li F, Zhang B, Zhang K, Zhang F, Huang X, Sun N, Ren Y, Sui M, Liu P. 2010. MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia. Schizophr Res 119(1):219-227.
37. Zhu Y, Kalbfleisch T, Brennan MD, Li Y. 2009. A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene. Schizophr Res 109(1):86-89.